Physiology, Pharmacology and Clinical Findings

  • Edward W. Flückiger
  • Emilio del Pozo
  • Klaus von Werder

Part of the Monographs on Endocrinology book series (ENDOCRINOLOGY, volume 23)

Table of contents

  1. Front Matter
    Pages I-X
  2. Edward W. Flückiger, Emilio del Pozo, Klaus von Werder
    Pages 1-23
  3. Edward W. Flückiger, Emilio del Pozo, Klaus von Werder
    Pages 24-64
  4. Edward W. Flückiger, Emilio del Pozo, Klaus von Werder
    Pages 65-101
  5. Edward W. Flückiger, Emilio del Pozo, Klaus von Werder
    Pages 102-152
  6. Edward W. Flückiger, Emilio del Pozo, Klaus von Werder
    Pages 153-218
  7. Back Matter
    Pages 219-226

About this book


Lactogenic hormone activity was first observed in bovine pituitary extracts by Stricker and Griiter in 1928, working in Bouin's laboratory in Strasbourg. Since that time prolactin has been shown to exist in anterior pituitary extracts of almost all vertebrate species investigated. Although its biology was extensively studied in many mammalian species, the existence of prolactin in the human was generally doubted, despite the positive evidence produced by such researchers as Pasteels. This can partly be explained by the fact that human growth hormone isolated in 1961, is itself a potent lactogen, in contrast to nonprimate growth hormones, and is present in the normal human pituitary in much greater amounts than prolactin. As a result there was a lag of nearly 10 years until prolactin was unanimously accepted as a hormone of the human pituitary, separate from human growth hormone. In 1970 new bioassay techniques permitted the demonstration of prolactin bioactivity in the serum of postpartum women and galactorrhea patients, and chromatographic methods led to the isolation and purification of human prolactin allowing the establishment of a specific radioimmunoassay for this hormone. This opened the road to the understanding of prolactin physiology and pathophysiology in the human, which has revolutionized clinical neuroendocrinology and reproductive endocrinology. Particularly hyperprolactinemia has turned out to be one of the most common endocrine syndromes.


Hyperprolactinämie Laktation Pharmacology neuroendocrinology pathophysiology physiology prolactin

Authors and affiliations

  • Edward W. Flückiger
    • 1
  • Emilio del Pozo
    • 2
  • Klaus von Werder
    • 3
  1. 1.Pharmaceutical Division, Preclinical ResearchSandoz Ltd.BasleSwitzerland
  2. 2.Pharmaceutical Division, Experimental TherapeuticsSandoz Ltd.BasleSwitzerland
  3. 3.Department of Medicine InnenstadtUniversity of MunichMunichFederal Republic of Germany

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1982
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-81723-6
  • Online ISBN 978-3-642-81721-2
  • Series Print ISSN 0077-1015
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Internal Medicine & Dermatology